Stock Events

Stock Events

Relmada Therapeutics (4E2.F) Q4 2024 Earnings

7NovConfirmed

Q2 2024

Q3 2024

Q4 2024

-0.79

-0.71

-0.62

-0.54

Details

Expected EPS

-0.62492175

Actual EPS

-0.6665832

Surprise EPS

-0.04

Surprise Percent

+6.67%

Description

Relmada Therapeutics (4E2.F) has reported earnings of -0.6665832 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.